Opinion: Biotech Startup ‘GeneSwift’ Closes $100M Series C The recent announcement of GeneSwift’s $100 million Series C biotech funding round isn’t just another headline; it’s…
·
·
7 min read
A staggering 70% of small to medium-sized businesses (SMBs) report difficulty securing traditional bank loans in 2025, pushing many to explore innovative alternative funding solutions.…
·
·
7 min read
ANALYSIS: The journey from a passion project to a fully funded venture is a dream for many aspiring developers, particularly within the booming interactive entertainment…
·
·
7 min read
Opinion: The common wisdom surrounding convertible notes and their associated discount rate in early-stage seed funding is fundamentally flawed, often costing founders significant equity and…
·
·
8 min read
Opinion: The conventional wisdom around startup funding often fixates on equity rounds, portraying them as the sole path to scaling. I disagree vehemently. For many…
·
·
8 min read
The venture capital market is a tempestuous sea, and even the most promising startups can find themselves adrift between funding rounds. This is precisely the…
·
·
8 min read
Key Takeaways Pre-seed investors prioritize founder tenacity and vision over polished products, often making decisions within the first 10 minutes of a pitch. A compelling…
·
·
8 min read
Key Takeaways Pre-revenue startup valuation relies heavily on qualitative factors like team strength and market potential, rather than traditional financial metrics. Investors prioritize a founder’s…
·
·
8 min read
The pharmaceutical industry is experiencing an unprecedented surge in investment directed towards bioinformatics for drug discovery, a trend that promises to reshape how new treatments…
·
·
8 min read
Y Combinator (YC) recently unveiled its latest batch of startups, showcasing a fascinating snapshot of emerging technologies and market demands. This cohort reveals significant shifts…
·
·
5 min read